IRIS Accounts Production v24.1.9.2 14471122 director 8.11.22 30.11.23 30.11.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh144711222022-11-07144711222023-11-30144711222022-11-082023-11-30144711222022-11-0714471122ns15:EnglandWales2022-11-082023-11-3014471122ns14:PoundSterling2022-11-082023-11-3014471122ns10:Director12022-11-082023-11-3014471122ns10:PrivateLimitedCompanyLtd2022-11-082023-11-3014471122ns10:Micro-entities2022-11-082023-11-3014471122ns10:AuditExempt-NoAccountantsReport2022-11-082023-11-3014471122ns10:FullAccounts2022-11-082023-11-3014471122ns10:RegisteredOffice2022-11-082023-11-3014471122ns5:CurrentFinancialInstruments2023-11-30
REGISTERED NUMBER: 14471122 (England and Wales)















Financial Statements for the Period 8 November 2022 to 30 November 2023

for

FTL Pharm Limited

FTL Pharm Limited (by shares) (Registered number: 14471122)

Contents of the Financial Statements
for the period 8 November 2022 to 30 November 2023










Page

Company Information 1

Balance Sheet 2


FTL Pharm Limited (by shares)

Company Information
for the period 8 November 2022 to 30 November 2023







DIRECTOR: Mr Fabrice Tohoya Lulengula





REGISTERED OFFICE: 143 Loughborough Road
Leicester
LE4 5LR





REGISTERED NUMBER: 14471122 (England and Wales)






FTL Pharm Limited (by shares) (Registered number: 14471122)

Balance Sheet
30 November 2023

£    £   
FIXED ASSETS 196

CURRENT ASSETS 18,613

CREDITORS
Amounts falling due within one year (8,558 )
NET CURRENT ASSETS 10,055
TOTAL ASSETS LESS CURRENT
LIABILITIES

10,251

CAPITAL AND RESERVES 10,251

NOTE TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was 1 .



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 26 July 2024 and were signed by:





Mr Fabrice Tohoya Lulengula - Director